These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 20233186

  • 1. Erice Statement 2009: communication, medicines and patient safety.
    Br J Clin Pharmacol; 2010 Feb; 69(2):207-8. PubMed ID: 20233186
    [No Abstract] [Full Text] [Related]

  • 2. The Erice Manifesto: for global reform of the safety of medicines in patient care.
    Drug Saf; 2007 Feb; 30(3):187-90. PubMed ID: 17343426
    [Abstract] [Full Text] [Related]

  • 3. Unhelpful information about adverse drug reactions.
    Tan K, Petrie KJ, Faasse K, Bolland MJ, Grey A.
    BMJ; 2014 Aug 12; 349():g5019. PubMed ID: 25115975
    [No Abstract] [Full Text] [Related]

  • 4. Reporting guidelines for pharmacoepidemiological studies are urgently needed.
    Etminan M.
    BMJ; 2014 Sep 17; 349():g5511. PubMed ID: 25231185
    [No Abstract] [Full Text] [Related]

  • 5. Striving for better patient information on adverse drug reactions.
    MacDonald J.
    BMJ; 2014 Sep 18; 348():g5513. PubMed ID: 25233934
    [No Abstract] [Full Text] [Related]

  • 6. Authors' reply to MacDonald and Etminan.
    Grey A, Tan K, Petrie KJ, Faasse K, Bolland MJ.
    BMJ; 2014 Sep 17; 349():g5523. PubMed ID: 25231263
    [No Abstract] [Full Text] [Related]

  • 7. European Medicines Agency assesses safety reporting at Roche.
    Marshall H.
    Lancet Oncol; 2012 Aug 17; 13(8):e331. PubMed ID: 23024993
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Can reporting of adverse drug reactions create safer systems while improving health data?
    Hohl C, Lexchin JR, Balka E.
    CMAJ; 2015 Aug 11; 187(11):789-790. PubMed ID: 25941261
    [No Abstract] [Full Text] [Related]

  • 10. [Evaluation of the website of the Nord-Pas-de-Calais regional pharmacovigilance center].
    Rochoy M, Béné J, Messaadi N, Auffret M, Gautier S.
    Therapie; 2016 Jun 11; 71(3):329-33. PubMed ID: 27235657
    [Abstract] [Full Text] [Related]

  • 11. Web-based patient-reported outcomes in drug safety and risk management: challenges and opportunities?
    Banerjee AK, Ingate S.
    Drug Saf; 2012 Jun 01; 35(6):437-46. PubMed ID: 22551007
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.
    Lorimer S, Cox A, Langford NJ.
    J Clin Pharm Ther; 2012 Apr 01; 37(2):148-52. PubMed ID: 21592157
    [Abstract] [Full Text] [Related]

  • 14. [Drug safety: from development to clinical use].
    Ovchinnikova EA, Gerasimov VB.
    Antibiot Khimioter; 2006 Apr 01; 51(6):15-22. PubMed ID: 17523417
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Communication of findings in pharmacovigilance: use of the term "signal" and the need for precision in its use.
    Hauben M, Reich L.
    Eur J Clin Pharmacol; 2005 Jul 01; 61(5-6):479-80. PubMed ID: 15991039
    [No Abstract] [Full Text] [Related]

  • 17. Harmonisation in pharmacovigilance.
    Edwards IR, Biriell C.
    Drug Saf; 1994 Feb 01; 10(2):93-102. PubMed ID: 8011183
    [No Abstract] [Full Text] [Related]

  • 18. An Evaluation of Indian Consumers' Reporting of Suspected Adverse Drug Reactions with a Designated Reporting Form.
    Rehan HS, Sah R, Gupta A, Nagar P.
    Curr Drug Saf; 2017 Feb 01; 12(1):51-56. PubMed ID: 27188794
    [Abstract] [Full Text] [Related]

  • 19. Report of Adverse Events in Colombia: A Successful Case.
    Moreno-Mattar O, Ramírez R, Alvarado A, Sierra F, Guzmán J.
    Curr Drug Saf; 2019 Feb 01; 14(1):53-56. PubMed ID: 30411692
    [Abstract] [Full Text] [Related]

  • 20. Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.
    Pierce CE, de Vries ST, Bodin-Parssinen S, Härmark L, Tregunno P, Lewis DJ, Maskell S, Van Eemeren R, Ptaszynska-Neophytou A, Newbould V, Dasgupta N, Wisniewski AFZ, Gama S, Mol PGM.
    Drug Saf; 2019 Apr 01; 42(4):477-489. PubMed ID: 30911975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.